Showing results (1051-1060 of 1,162) with videos related to

Sort By:
Pageof 117
Asian Journal of Endoscopic Surgery|November 25, 2025
Consensus Meeting of Anatomy on the Border, Appropriate Use and Precautions for ICG in Liver, Lung, and Renal SurgeryJunji Ichinose, Shinji Itoh, Shintaro Narita, et al.
The Lancet. Gastroenterology & Hepatology|October 16, 2025
Thoracoscopic versus open oesophagectomy for patients with oesophageal cancer (JCOG1409 MONET): a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trialHiroya Takeuchi, Ryunosuke Machida, Masahiko Ando, et al.
Oncogene|August 6, 2025
MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progressionHiroki Ozawa, Yin Wang, Henry G Withers, et al.
Annals of Gastroenterological Surgery|January 6, 2025
Annual report on National Clinical Database 2021 for gastroenterological surgery in JapanSunao Ito, Arata Takahashi, Hideki Ueno, et al.
The British Journal of Surgery|February 20, 2024
Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinomaJun Okui, Kengo Nagashima, Satoru Matsuda, et al.
Japanese Journal of Clinical Oncology|October 5, 2020
A multicenter non-randomized phase III study of sentinel node navigation surgery for early gastric cancerSatoshi Kamiya, Hiroya Takeuchi, Kazumasa Fukuda, et al.
Lancet (London, England)|June 14, 2024
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trialKen Kato, Ryunosuke Machida, Yoshinori Ito, et al.
Development (Cambridge, England)|June 4, 2017
Placental labyrinth formation in mice requires endothelial FLRT2/UNC5B signalingIkue Tai-Nagara, Yusuke Yoshikawa, Naoko Numata, et al.
The Lancet. Oncology|October 5, 2019
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trialKen Kato, Byoung Chul Cho, Masanobu Takahashi, et al.
Annals of Surgical Oncology|October 7, 2024
Prognostic Impact of Thoracic Duct Resection in Patients Who Underwent Transthoracic Esophagectomy Following Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: Exploratory Analysis of JCOG1109Satoru Matsuda, Hiroya Takeuchi, Ken Kato, et al.
Pageof 117